Infection and Immunity, January 2001, p. 1-8, Vol. 69, No. 1
Ups and Downs of Mucosal Cellular Immunity against
Protozoan Parasites
Departments of Medicine (Neurology) and Microbiology,
Dartmouth Medical School, Lebanon, New Hampshire
03756,1 and Faculte de Pharmacie,
Laboratoire INRA-Universite d'Immunite Parasitaire, 37200 Tours,
France2
The intestinal mucosa provides both
a physiologic and immunologic barrier to a wide range of microorganisms
and foreign substances. In general, the mucosal immune system is
homeostatic despite the considerable antigenic load in the intestine.
When an imbalance does occur in the regulation of this response, gut
barrier dysfunction and inflammatory bowel disease are observed.
Protozoan parasites that gain access to the host through the mucosal
tissue of the alimentary tract may influence the development of such
intestinal inflammatory disorders. Gut inflammatory diseases are
associated with the production of various inflammatory cytokines
including interleukin-1 (IL-1), IL-8, or tumor necrosis factor alpha
(TNF- A number of immune mediators are potentially involved in downregulation
of the inflammatory response. Two cytokines, in particular, transforming growth factor Another cytokine associated with downregulation is IL-10 that can be
produced by a large variety of immune cells, including T lymphocytes,
that express the Th2 phenotype, B cells, and macrophages. IL-10 can
downregulate IFN- Intestinal immune homeostasis is dependent upon the successful
interaction of several compartments within the intestinal tract. These
include organized secondary lymphoid organs, such as mesenteric lymph
nodes, Peyer's patches, and leukocytes that are dispersed throughout
the intestinal wall and within the mucosa, the intraepithelial lymphocytes (IEL). Epithelial cells or enterocytes lining the alimentary tract serve both as a physiologic barrier separating the
lumen from underlying tissues and as a source of immune inflammatory products. These enterocytes or immunocytes play a critical role in
mucosal immunophysiology that in part consists of a paracrine network
between enterocytes and the underlying immune and inflammatory cells.
A number of protozoan parasites including Giardia
intestinalis and Giardia lamblia, Cryptosporidium
parvum, T. gondii, Eimeria spp., and
Entamoeba histolytica have been shown to adhere to and to
multiply on or within enterocytes (89). Attachment to
enterocytes appears essential for colonization of the intestine and is
requisite for the induction of host immunity that will lead to
enterocyte damage (39). Intestinal inflammation invariably
is associated with an increase in epithelial cell proliferation
(59). In the small bowel the pathologic consequences of
this response include proliferation in the crypt and a decrease in the
number of enterocytes in the absorptive villus compartment, which can
lead to malabsorption. For the host, this proliferation will presumably
rid the intestine of infected and damaged enterocytes that can be
quickly replaced.
One mechanism utilized by the host for effective control and removal of
intestinal acquired parasites is the induction of NO by the intestinal
epithelium. NO is antimicrobial for a wide range of mucosal pathogens
(13, 21, 37) and, furthermore, is involved in the
regulation of mucosal barrier integrity and vascular tone in the gut
(2). NO is produced enzymatically from arginine through
the action of NO synthase (NOS), which in many cell types, including
intestinal epithelial cells, is expressed in its inducible isoform
(81, 97). Expression of inducible NOS is constitutive in
the mouse ileum and isolated normal duodenocytes (32) or
is inducible in vivo during colonic inflammation or in vitro by
cytokines or in response to infection with invasive bacteria
(81). In polarized intestinal epithelial cells, the stable
NO end products, nitrite and nitrate, are preferentially detected on
the apical side, suggesting that relevant targets for epithelial
cell-derived NO and its metabolites may be located on the luminal side
of the cells (97). Giardia infection of the
human intestine is a common protozoan infection and is the cause of
self-limited diarrheal disease worldwide. Giardia infection is restricted to the lumen of the intestinal tract. NO inhibits growth,
encystation, and excystation of G. lamblia, but has no effect on giardial viability (20). Despite the potent
antigiardial activity of NO, G. lamblia is not simply a
passive target for host-produced NO but has strategies to evade this
potential host defense. In models of human intestinal epithelium,
G. lamblia inhibited epithelial NO production by consuming
arginine, the crucial substrate used by epithelial NO synthase to form NO.
In C. parvum infection the interaction between the parasite
and enterocytes leads to diarrhea, which is characterized by the impairment of glucose-stimulated Na+ absorption, a function
principally of villus-absorptive cells (67). When
infected, these cells express an increase in their prostaglandin
production (3, 47) which can inhibit NaCl absorption and
result in secretory diarrhea. In addition to altering epithelial chloride and fluid secretion, increased prostaglandin can upregulate epithelial mucus expression, which could protect the host against further infection and downregulate inflammatory cytokine production by
macrophages. Recently, it has been demonstrated that epithelial cells
infected with C. parvum undergo caspase-dependent apoptosis, which may further lead to the clinical manifestations associated with
enteric infection (72), in particular, the cytolysis of the parasitized mucosa. Parasite may use apoptosis to exit from the
infected cell or the infected cell may eliminate the parasite through
apoptosis. However, C. parvum has developed strategies to
limit apoptosis in order to facilitate growth and maturation in the
early period following epithelial cell infection (63).
Intestinal acquired parasites may directly induce the production of
chemokines by epithelial cells. These chemokines may be critical to the
initiation of the mucosal inflammatory process. C. parvum
resides in epithelial cells, and infection of human intestinal
epithelial cells in vitro results in upregulated expression and
basolateral secretion of C-X-C chemokines IL-8 and GRO Cell-cell interaction within the intestinal lumen may be altered by
protozoan infection. E. histolytica trophozoites colonize the lumen and may disrupt the epithelial tight junction. The principal clinical manifestation of the infection is due to loss of this epithelial barrier with deterioration of normal physiologic function. As the infection progresses, the cytotoxic effects of the parasite as
well as molecular changes in the tight junction protein complex (52) may further aggravate the process. The tight junction
complex constitutes, after the mucus, the first barrier against the
paracellular penetration of intestinal microorganisms. This
intercellular barrier is formed by the plasma membrane-spanning
proteins claudins (24) and occludin (25) that
associate with different peripheral plasma membrane proteins such as
the ZO. Tight junction complexes are linked to the actin cytoskeleton
(60). Selective disturbance of tight junction complexes by
trophozoites from E. histolytica results in the rapid
decrease of the transepithelial electrical resistance caused by an
increase in paracellular permeability (51, 54, 61).
In addition to alterations in the tight junction, infection with
E. histolytica can stimulate the production of IL-8 from human colonic epithelial cells (99) in the absence of
cell-cell contact or injury. Experimental models demonstrate that the
epithelial cells in response to parasite infection produced IL-1 and
IL-8 (85). In vivo, infection of xenografts with E. histolytica trophozoites results in extensive tissue damage
associated with infiltration of neutrophils. Human intestinal
epithelial cell inflammatory responses to amebic infection were
inhibited by the intraluminal administration of an antisense
oligonucleotide to the human p65 subunit of NF- Intestinal epithelial cells constitutively express major
histocompatibility complex (MHC) class II, and this expression is enhanced in states of inflammation (62). These enterocytes
can take up soluble antigens into an endolysosomal pathway, including class II-containing compartment. This suggests that all the mechanisms required for antigen processing and presentation exist within the
enterocytes and that MHC class II expressed on murine enterocytes is
functional (38). However, intestinal epithelial cells lack the costimulatory B7-1 and B7-2 expression, suggesting that enterocytes are poor antigen-presenting cells compared to dendritic cells or
macrophages (5). In an antigen-overloaded environment such as the intestine, the failure of classical class II-mediated activation may be beneficial. Since most intraepithelial lymphocytes (see below)
are CD8+, class II restriction may not be involved. There
may however be distinct surface molecules and restriction elements that
can present processed antigen to CD8 T cells. These include the
expression of the class Ib molecule CD1d as well as the gp180 CD8
ligand. However, in spite of the close juxtaposition of IEL and
enterocytes, allogenic coculture of these cells fails to result in
T-cell activation. Recent data suggests that CD1d and gp180 molecules
together may activate a subpopulation of CD8+ regulatory T
cells which function to suppress the immune response in an
antigen-nonspecific fashion (11). These observations
suggest that enterocytes may be a key component in the immune
homeostasis in the gut.
Oral acquisition of a parasite may result in a robust innate
mucosal immune response in the infected host (Fig.
1). This response may include activation
of neutrophils, tissue macrophages, monocytes, dendritic cells,
and eosinophils. Many of these early-phase reactive cells are essential
for the protective response as well as the establishment of long-term
immunity to the parasite. Induction of chemokines such as IL-8 and
GRO
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.1.1-8.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
MINIREVIEW
![]()
INTRODUCTION
Top
Introduction
Conclusion
References
) and gamma interferon (IFN-
) that may be produced by
mucosal epithelial cells or by neighboring cells from the immune
system. These immune products may act as chemoattractants (chemokines)
for specific inflammatory cells, including macrophages, monocytes,
neutrophils, and lymphocytes, that contribute to the mucosal
inflammation. Elevated levels of nitric oxide (NO)-derived metabolites
have been associated with these Th1-mediated inflammatory disorders. Although this proinflammatory response may be necessary to clear the
infection it may invoke pathologic and potentially destructive changes
in the tissue. In normal physiologic conditions, a homeostatic balance
is maintained and the inflammatory disorders are prevented by
downregulation of the immune response in the intestine.
(TGF-
) and IL-10, appear to be
candidates responsible for the downregulation of NO production. TGF-
is a potent immunoregulatory agent that affects proliferation (1, 82), the state of activation (69, 73) and
differentiation (76) of the T-cell response. TGF-
may
impair IL-12 production (74) that stimulates IFN-
synthesis and the proliferation of both T and NK cells. TGF-
alters
expression of T-cell costimulatory molecules, in particular, CD40/CD154
interactions that are responsible for the production of IL-12
(91). Recent studies involving genetically impaired mice
for some members of the TGF-
family emphasize the role of TGF-
as
a master regulator of immune cell function (53).
synthesis by Toxoplasma
gondii-stimulated NK cells (88) and T cells
(41) as well as a wide variety of macrophage-derived
proinflammatory monokines (66), suggesting a critical role
in macrophage effector functions against different pathogens
(26). IL-10 inhibits IFN-
synthesis by NK and Th1 lymphocytes via inhibition of macrophage IL-12 synthesis
(34). IL-10 is associated with the downregulation of the
expression of costimulatory molecules, which are implicated in the
immunopathology observed after T. gondii infection
(94).
![]()
PARASITE-ENTEROCYTE INTERACTION
(47). These results were expanded in a model of human
intestinal xenografts in SCID-HU-INT mice. After C. parvum
infection in vivo, human intestinal epithelial cells produced IL-8 in
association with TNF-
and IL-1
(87). Unlike
enteroinvasive bacteria, the kinetics of increased expression and
production of IL-8 and GRO
after C. parvum infection was
delayed and most marked 16 to 48 h after infection (46,
48). Although acquired by oral ingestion, T. gondii
that invades the epithelial cells of the intestine is not usually
considered an enteric pathogen. However, inflammatory bowel disease
(IBD) has been observed following oral infection in monkeys
(15) as well as in rabbits. Similar evidence of IBD has
been reported in certain strains of inbred mice following oral
infection with T. gondii (55). This
hyperinflammatory process is associated with the early mortality of
these susceptible mouse strains. Recent studies in our laboratory have
suggested that both murine and human enterocytes when infected with
T. gondii produce significant quantities of proinflammatory
chemokines, among which are IP-10, MCP-1, and MIP-2 (10a).
Using an in vitro system, we have determined that parasite-infected
enterocytes are chemoattractant for several different cell types,
including CD8+ intraepithelial lymphocytes within the
mucosal compartment (D. Buzoni-Gatel et al., unpublished observation).
B. This treatment
blocked the production of human IL-1
and IL-8 by intestinal
epithelial cells and inhibited neutrophil influx into the E. histolytica-infected intestinal xenografts. These data emphasize
the role of the intestinal epithelial cell in initiating the
inflammatory intestinal response after infection with E. histolytica (86). Other inflammatory
molecules, including granulocyte-macrophage colony-stimulating factor
(GM-CSF) and IL-1
/
mRNAs, were up regulated by E. histolytica infection (44).
![]()
PARASITE AND INNATE IMMUNITY
play an important role in the chemoattraction and activation of
neutrophils. Polymorphonuclear leukocyte (PMN) attraction and
accumulation may participate in the development of the intestinal
lesion (86) as already illustrated in amebic infection. In
those studies, it was demonstrated that depletion in PMN or inhibition
of their attraction into the infected intestine results in prevention
of the development of intestinal lesions.

View larger version (136K):
[in a new window]
FIG. 1.
A model of intestinal mucosal immune response to orally
acquired protozoa. After oral infection, some parasites come in direct
contact with the enterocytes (Giardia), whereas
Entamoeba may disturb the intercellular tight junctions as
well as induce lysis of the epithelial cells. Other parasites, such as
C. parvum and T. gondii, are more invasive and
penetrate into enterocytes or IEL (Eimeria). The infected
enterocyte may fend off the microbe by the production of NO as well as
various chemokines that participate in the chemoattraction of
neutrophils (PMN) and different antigen (Ag)-presenting cells, such as
macrophages (M
), monocytes, and dendritic cells (DC) from Peyer's
patches, mesenteric lymph nodes, or the lamina propria (lamina propria
lymphocytes [LPL]). In addition to their effect against parasites,
these early inflammatory cells contribute both to the development of
the pathogenesis of the intestinal immune process and to the initiation
of a long-lasting immunity by activation of T and B cells. Although an
essential component to the host defense, IFN-
that can be produced
by intestinal T cells is also the principal cause of inflammation in
the intestine. Other cytokines, such as TNF-
, together with IFN-
may have a synergistic effect. Homeostatic mechanisms to control the
hyperinflammatory response are induced. Cells throughout the intestine
participate in the control of this response by the secretion of two
essential downregulatory cytokines, TGF-
and IL-10.
PMN accumulation is commonly associated with inflamed intestine, this
accumulation being due, in part, to a delay in the apoptotic process
(35). The lack of apoptosis may result from the activity of G-CSF and GM-CSF (J. Y. Channon, K. Miselis, L. Minns, and L. H. Kasper, submitted for publication). The PMNs are an important source
of proinflammatory cytokines, such as IL-1
and TNF-
, and fully
participate to the immune response in the intestine. Infection with
C. parvum results in a spectrum of pathologic changes in the
intestine accompanied by patchy or large neutrophil and mononuclear
infiltrates. Neutrophils in mucosal secretions retain their ability to
phagocytose and kill pathogens (18). In addition, neutrophils may function to regulate other aspects of the inflammatory response through the secretion of chemokines (57) at the
site of infection.
As noted above, parasite-infected epithelial cells produce a variety of
chemokines, including MCP-1, which may be involved in macrophage
migration to the site of infection. Macrophages are well-known
mediators of the host innate response to a large array of microbial
pathogens. Macrophages and monocytes can control and kill parasites by
both oxidative and nonoxidative mechanisms. Parasite infection of
intestinal tissue will lead to a robust inflammatory process and the
production of a wide range of cytokines, such as IFN-
, TNF-
, and
IL-1. Intestinal inflammation is characterized by a strong Th1 response
and macrophages are important during mucosal inflammation. In situ
expression of cell adhesion molecules, such as ICAM-1, may increase
recruitment and further sustain the inflammatory process
(68). Lamina propria macrophages isolated from patients
with IBD display high levels of NF-
B DNA binding activity,
accompanied by increased production of IL-1, IL-6, and TNF-
(33, 70). Other cytokines, such as IL-15 and IL-18
(65), enhance IFN-
production, which further enhances
macrophage function.
IFN-
-activated macrophages exhibit microbicidal activity by
production of high levels of NO (17), which is toxic for a variety of orally acquired parasites. IFN-
-primed macrophages produce TNF-
in response to the Gal-lectin antigen of E. histolytica (84), which in turn promotes NO-mediated
cytotoxicity against the parasite. Giardia trophozoites are
susceptible to the effect of IFN-
-activated macrophages
(22), presumably through NO-mediated toxicity. Treatment
of chicken bone marrow macrophages with IFN-
inhibits intracellular
E. tenella replication via NO or toxic oxygen intermediates
(17). T. gondii is sensitive to the presence of
NO in the mucosa following oral infection (42). IFN-
activation can enhance microbiostatic activity independent of the
production of NO residues. For example, IFN-
treatment may lead to
the intracellular deprivation of tryptophan and iron, which can be
deleterious for T. gondii replication in both macrophages
and enterocytes (16, 75). In addition to their role in
innate immunity, the macrophages amplify the specific acquired immune
response and are necessary for antigen presentation that provides for
long-term protection against recurrent infection. However, macrophages
may also serve as long-term host cells that facilitate the replication
and survival of the pathogens and thereby serve as a vector for the
invasion of the parasite (8).
Other first-line defense cells may be recruited to the site of infection. Secretion of chemokines may result in the migration and activation of dendritic cells or lamina propria cells to the site of mucosal infection (40). Peyer's patches represent the primary site for uptake and presentation of ingested antigens in the intestine. There are at least two different populations of dendritic cells in the Peyer's patches. Although there is mounting information indicating that dendritic cells play an important accessory function in response to a number of pathogens, including T. gondii (78, 83), there is currently very little information on the role of mucosal dendritic cells in response to protozoan infection.
One of the unique features of mucosal lymphoid tissue such as Peyer's
patches is their capacity to induce Th cells producing type 2 (IL-4,
IL-5, and IL-10) and type 3 (TGF-
) cytokines. Induction of the Th
cell response is important for immunoglobulin A (IgA) production and
generation of regulatory cell-mediated oral tolerance. Despite this
ability to generate Th2/Th3 responses in mucosal tissues, distinct Th1
responses occur in the mucosa, particularly following intestinal
infection with pathogenic microorganisms such as T. gondii
or in IBD (36). The mechanisms that determine the ability
of Peyer's patches to generate TH2/Th3 responses yet allow for the
differentiation of Th1 response after infection with pathogenic
organisms remain uncertain. One possibility is that alteration of the
cytokine environment in the intestinal mucosa favors the
differentiation of Th2 and Th3 cells, but that pattern is overridden by
strong signals from pathogens, such as those that directly induce IL-12
from antigen-presenting cells. Another important factor may be the
nature of the resident antigen-presenting cells, compared to the cells
that traffic to the infected sites. Resident dendritic cells may differ
in their capacities to drive T-cell differentiation.
The role of eosinophils in determining the outcome of parasite infections is mentioned in some studies. Early studies using T. gondii have demonstrated that IgE-bearing eosinophil can be cytotoxic (79). Regarding E. histolytica infection, in vitro data suggest that unlike normal human eosinophils which are destroyed, eosinophils which have been activated by complement and armed with specific IgE antibodies effectively destroy virulent E. histolytica (58). Unfortunately, the clinical relevance of this finding is uncertain since amoebic colitis does not appear to be associated with intestinal eosinophilia.
| |
IEL AND INFECTION |
|---|
In the intestine, the mucosal immune system consists of organized
secondary lymphoid organs, such as mesenteric lymph nodes and Peyer's
patches, as well as leukocytes dispersed throughout the intestinal wall
and particularly in the mucosa. Mucosal lymphocytes, the IEL, are
located between epithelial cells, below the intercellular tight
junctions, and express a set of surface receptors different from those
of peripheral blood lymphocytes and comprise a phenotypically distinct
population. Although some differences exist between humans and animals,
more specifically mice, most of the IEL are T lymphocytes and bear an
oligoclonal repertoire of T-cell antigen receptor (TCR). The TCR has
two forms, 
and 
. In the intestinal epithelia of numerous
vertebrate hosts, TCR-
T cells are often present in large
numbers. Up to 90% of IEL are CD4
CD8+, and
most of these (60%) express the CD8 homodimer 
. The other population of CD8+ cells bears the CD8 heterodimer 
(29). Most IEL express the unusual integrin
E
7,
which is involved in adherence to epithelial cells by binding to
E-cadherin. Although some IEL may develop within the epithelium
(77), it is likely that many IEL traffic from blood
vessels present in the lamina propria to the epithelium. The IEL
deficiency associated with a lack of
7 expression suggests that
E
7 is required for entry and/or retention of T cells in the
intestinal epithelium (45, 96). T-cell activation results in the accumulation of
E
7hi cells in the mesenteric
lymph nodes, lamina propria, and IEL compartment, suggesting also a
role for this molecule in lymphocyte homing. Synthesis of the
E
subunit is induced by the TGF-
cytokine (4, 43). This
cytokine is abundant in the gut epithelial cells, located in the distal
region of the villus, and can induce
E synthesis in T cells
following migration into the epithelial microenvironment. Another
integrin,
4
7, expressed in low frequency on IEL is evident on
lamina propria lymphocytes and on approximately 50% of T cells
(6, 71).
Activated lymphocytes expressing
4
7 can bind to several
receptors, the most prominent of which is MadCAM-1, a protein expressed by high endothelial venule (HEV) cells in Peyer's patches and mesenteric lymph nodes and the flat endothelium in the lamina propria
(6, 92). Studies indicate that the interactions of
4
7 and MadCAM-1 play a major role in lymphocyte homing to
Peyer's patches, lamina propria, and mesenteric lymph nodes
(31). Diapedesis from the microvasculature occurs in
response to the expression of the
4
7 molecule.
Although the migration of T cells into the intestinal epithelium is not
fully understood, IEL have in vitro chemotactic activity in response to
several different chemokines, including IL-8, RANTES, MCP, MIP, crg-2,
and MuMig (murine monokine induced by gamma interferon), all of which
can be produced by activated enterocytes (80). Infection
of the gut with mucosal pathogens can result in the migration and
activation of IEL. Infection with Eimeria vermiformis, results in an increase in the number of recoverable IEL at 3 and 14 days postinfection. The IEL repertoire, and, more precisely, the

+ T-cell repertoire, has been shown to be very
dynamic postinfection with a naturally occurring epithelialtropic
pathogen (23). Following G. lamblia infection
in inbred mice, quantitation of T-cell subsets in the intraepithelium
(IEL) and lamina propria revealed increased influx of CD8 T cells and
Thy1.2+ T cells followed by an increase in CD4 T cells in
the lamina propria (95). IEL provide a number of important
immunologic functions, including cytotoxic activity (28,
29), secretion of cytokines including IL-2, IL-3, IL5, TNF-
,
TGF-
, IL-10, and IFN-
(30, 49), and modulation of
epithelial cell death and regeneration.
Evidence that IEL population in the intestine has a major role in
immunity has been obtained from experimental studies of in vivo
infection with Toxoplasma and Cryptosporidium
spp. Adoptive transfer of T. gondii antigen-primed IEL into
the naïve host provide long-term protection following lethal
parasite challenge as determined by reduced mortality and decreased
number of brain cysts in the recipient. The protective IEL are
CD8+
/
+,
/
TCRs and are partially
dependent upon the presence of intact
/
TCRs as well as
endogenous production of IFN-
(10, 50) in the recipient
host. Increased expression of the activated memory T-cell phenotype, in
particular Ly-6C, was noted in the protective IEL cell population.
T. gondii antigen-primed IEL can traffic to the intestine
and stimulate long-term immunity to reinfection. The ability of these
cells to traffic to the intestine is dependent upon the expression of
the appropriate integrins which if blocked increases susceptibility to
parasite challenge. A combined treatment with anti-
4 and anti-
E
monoclonal antibodies partially inhibited IEL trafficking and
impaired host resistance to T. gondii (9). The
predominant functional role of
E
7 is to retain lymphocytes within
or closely apposed to epithelial cells. Since IEL are cytotoxic for
T. gondii-infected enterocytes in vitro (12),
E
7 may play an integral role in that interaction. Intestinal
epithelial cells inhibit the proliferative and cytokine responses of
intraepithelial T cells (98) and may be involved in
control of the extensive intestinal hyperinflammatory response in
certain strains of mice (42, 55). We have observed
that T. gondii antigen-primed IEL produce
substantial amounts of TGF-
. The mucosal inflammatory process observed after oral infection with T. gondii in
susceptible C57BL/6 mice is mediated by NO. The inflammation can be
reversed when susceptible mice are treated with an NO blocking agent,
such as aminoguanidine. Observations to date suggest that local
production of IFN-
perhaps from the CD4 lymphocytes in the lamina
propria or NK cells may be responsible for this activity.
Supplementation of exogenous TGF-
to susceptible mice reverses the
hyperinflammation, whereas treatment of resistant strains such as CBA
with a blocking antibody to TGF-
renders them susceptible. In vitro,
coculture of antigen-primed IEL can reverse IFN-
synthesis of primed
splenocytes perhaps via a TGF-
-mediated pathway (Kasper et al., submitted).
IL-10 appears to be an important component in maintaining gut homeostasis in response to orally acquired pathogens. Increased mortality of IL-10 knockout (KO) mice is presumed secondary to the abnormally high inflammatory cytokine response during acute toxoplasmosis (27). Mice deficient in IL-10 synthesis exhibit increased inflammation in their intestines following oral infection with T. gondii (90). Mice that have been reconstituted with the gene for IL-10 expressed on the IL-2 promoter regain their ability to control the hyperinflammation (K. Ely, unpublished observation). The source for IL-10 production within the infected intestine is as yet undetermined.
In Cryptosporidium muris infection, immunity can be
adoptively transferred to SCID mice using postinfection intestinally
derived IEL. Of note however, in contrast to T. gondii
infection, protection was associated with the CD4+ T-cell
population as opposed to CD8+ (14). When
adoptively transferred into SCID mice, primed IEL traffic back to the
intestine. IEL from C. muris-infected mice produce
significant quantity of IFN-
in the presence of antigen-presenting cells. Treatment of recipient mice with anti-IFN-
abrogated the protection (14, 64). This is similar to the observations
made following adoptive transfer of T. gondii antigen-primed
CD8+. Of note is that transfer of primed CD8+
IEL from wild-type mice into IFN-
KO mice failed to protect against
a T. gondii challenge (50). In contrast,
adoptive transfer of IEL from IFN-
KO mice into the wild type is
protective. These data suggest that host IFN-
is essential for
protection. Although less documented, the possible implication of IEL
in anti-Giardia immunity has been suggested. Human
CD4+ T lymphocytes from the intestine proliferate in
response to Giardia infection and produce IFN-
. Moreover,
murine intraepithelial lymphocytes from a Giardia-infected
host are cytotoxic to the parasite (19).
IEL may be associated with the parasite life cycle. A study by transmission electron microscopy performed with mice after infection with sporozoites of T. gondii reveals that sporozoites passed through intestinal epithelial cells and infected a number of different cell types within the lamina propria. Sporozoites did not infect intraepithelial lymphocytes, but at 48 h postinfection, IEL could be infected with tachyzoites arising from those that had developed in the lamina propria (89). In chickens, Eimeria multiplication occurs within enterocytes and the sporozoites of some species such as E. tenella enter the epithelium at the villous tip but migrate to the crypt where intracellular development commences. Sporozoites at the villous tip transfer from epithelial cells to IELs and are then translocated within these cells via the lamina propria to the crypt. CD8 cells are mostly the carrier of the sporozoites (56). Eimeria infections induce changes in the intestinal intraepithelial population (7, 23). Growth of the parasite in the intestinal epithelium leads to the development of the host immune response and CD8+ cells, which increased in number after challenge infection, seem to act as effector cells in acquired immunity (93).
| |
CONCLUSION |
|---|
|
|
|---|
Many pathogens are acquired via ingestion and invasion of the intestinal tract. Despite the diversity of the extracellular and intracellular pathogens discussed in this review, our current understanding of the mechanisms involved in the immune response indicates that a common exuberant immune response to rid the host of these agents is elicited. This robust inflammatory response is controlled by a series of regulatory mechanisms in most species. When this balance is no longer evident, a lethal inflammation of the intestine may occur, such as IBD or acute ileitis. The delicate balance between these dichotomous responses provides the host with protection against the pathogen yet maintains the integrity of the mucosal surface.
| |
ACKNOWLEDGMENTS |
|---|
This work was supported by NIH grants AI 19613, AI 30000, and TW01003.
We thank Jacqueline Y. Channon and Franck Mennechet for thoughtful review of the manuscript.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Microbiology, Dartmouth Medical School, Borwell Building 640W, One Medical Center Dr., Lebanon, NH 03756. Phone: (603) 650-8787. Fax: (603) 650-8799. E-mail: lloyd.kasper{at}dartmouth.edu.
Editor: D. A. Portnoy
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Ahuja, S. S., F. Paliogianni, H. Yamada, J. E. Balow, and D. T. Boumpas. 1993. Effect of transforming growth factor-beta on early and late activation events in human T cells. J. Immunol. 150:3109-3018[Abstract]. |
| 2. |
Alican, I., and P. Kubes.
1996.
A critical role for nitric oxide in intestinal barrier function and dysfunction.
Am. J. Physiol.
270:G225-G237 |
| 3. | Argenzio, R. A., J. A. Liacos, M. L. Levy, D. J. Meuten, J. G. Lecce, and D. W. Powell. 1990. Villous atrophy, crypt hyperplasia, cellular infiltration, and impaired glucose-Na absorption in enteric cryptosporidiosis of pigs. Gastroenterology 98:1129-1140[Medline]. |
| 4. | Austrup, F., S. Rebstock, P. J. Kilshaw, and A. Hamann. 1995. Transforming growth factor-beta 1-induced expression of the mucosa-related integrin alpha E on lymphocytes is not associated with mucosa-specific homing. Eur. J. Immunol. 25:1487-1491[Medline]. |
| 5. |
Barrett, T. A.,
Y. Tatsumi, and J. A. Bluestone.
1993.
Tolerance of T cell receptor gamma/delta cells in the intestine.
J. Exp. Med.
177:1755-1762 |
| 6. | Berlin, C., E. L. Berg, M. J. Briskin, D. P. Andrew, P. J. Kilshaw, B. Holzmann, I. L. Weissman, A. Hamann, and E. C. Butcher. 1993. Alpha 4 beta 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. Cell 74:185-196[CrossRef][Medline]. |
| 7. | Bessay, M., Y. Le Vern, D. Kerboeuf, P. Yvore, and P. Quere. 1996. Changes in intestinal intra-epithelial and systemic T-cell subpopulations after an Eimeria infection in chickens: comparative study between E. acervulina and E. tenella. Vet. Res. 27:503-514[Medline]. |
| 8. | Bogdan, C., and M. Rollinghoff. 1999. How do protozoan parasites survive inside macrophages? Parasitol. Today 15:22-28[CrossRef][Medline]. |
| 9. |
Buzoni-Gatel, D.,
H. Debbabi,
M. Moretto,
I. H. Dimier-Poisson,
A. Lepage,
D. T. Bout, and L. H. Kasper.
1999.
Intraepithelial lymphocytes traffic to the intestine and enhance resistance to Toxoplasma gondii oral infection.
J. Immunol.
162:5846-5852 |
| 10. | Buzoni-Gatel, D., A. C. Lepage, I. H. Dimier-Poisson, D. T. Bout, and L. H. Kasper. 1997. Adoptive transfer of gut intraepithelial lymphocytes protects against murine infection with Toxoplasma gondii. J. Immunol. 158:5883-5889[Abstract]. |
| 10a. | Burzoni-Gatel, D., H. Debbabi, F. D. Menneclat, J. Martin, A. C. Lepage, J. D. Schwartzman, and L. H. Kasper. Acute
inflammatory ileitis after intracellular parasite infection is
controlled by TGF- producing intraepithelial lymphocytes.
Gastroenterology, in press.
|
| 11. | Campbell, N., X. Y. Yio, L. P. So, Y. Li, and L. Mayer. 1999. The intestinal epithelial cell: processing and presentation of antigen to the mucosal immune system. Immunol. Rev. 172:315-324[CrossRef][Medline]. |
| 12. | Chardes, T., D. Buzoni-Gatel, A. Lepage, F. Bernard, and D. Bout. 1994. Toxoplasma gondii oral infection induces specific cytotoxic CD8 alpha/beta+ Thy-1+ gut intraepithelial lymphocytes, lytic for parasite-infected enterocytes. J. Immunol. 153:4596-4603[Abstract]. |
| 13. | Clark, I. A., and K. A. Rockett. 1996. Nitric oxide and parasitic disease. Adv. Parasitol. 37:1-56[Medline]. |
| 14. | Culshaw, R. J., G. J. Bancroft, and V. McDonald. 1997. Gut intraepithelial lymphocytes induce immunity against Cryptosporidium infection through a mechanism involving gamma interferon production. Infect. Immun. 65:3074-3079[Abstract]. |
| 15. | Dietz, H. H., P. Henriksen, V. Bille-Hansen, and S. A. Henriksen. 1997. Toxoplasmosis in a colony of New World monkeys. Vet. Parasitol. 68:299-304[CrossRef][Medline]. |
| 16. | Dimier, I. H., and D. T. Bout. 1998. Interferon-gamma-activated primary enterocytes inhibit Toxoplasma gondii: a role for intracellular iron. Immunology 94:488-495[CrossRef][Medline]. |
| 17. | Dimier, I. H., P. Quere, M. Naciri, and D. T. Bout. 1998. Inhibition of Eimeria tenella development in vitro mediated by chicken macrophages and fibroblasts treated with chicken cell supernatants with IFN-gamma activity. Avian Dis. 42:239-247[CrossRef][Medline]. |
| 18. | Ebenfelt, A., H. Lundqvist, C. Dahlgren, and C. Lundberg. 1996. Neutrophils in mucosal secretion are functionally active. Clin. Exp. Immunol. 106:404-409[CrossRef][Medline]. |
| 19. |
Ebert, E. C.
1999.
Giardia induces proliferation and interferon gamma production by intestinal lymphocytes.
Gut
44:342-346 |
| 20. |
Eckmann, L.,
F. Laurent,
T. D. Langford,
M. L. Hetsko,
J. R. Smith,
M. F. Kagnoff, and F. D. Gillin.
2000.
Nitric oxide production by human intestinal epithelial cells and competition for arginine as potential determinants of host defense against the lumen-dwelling pathogen Giardia lamblia.
J. Immunol.
164:1478-1487 |
| 21. | Fang, F. C. 1997. Perspectives series: host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity. J. Clin. Investig. 99:2818-2825[Medline]. |
| 22. | Fernandes, P. D., and J. Assreuy. 1997. Role of nitric oxide and superoxide in Giardia lamblia killing. Braz. J. Med. Biol. Res. 30:93-99[Medline]. |
| 23. | Findly, R. C., S. J. Roberts, and A. C. Hayday. 1993. Dynamic response of murine gut intraepithelial T cells after infection by the coccidian parasite Eimeria. Eur. J. Immunol. 23:2557-2564[Medline]. |
| 24. |
Furuse, M.,
K. Fujita,
T. Hiiragi,
K. Fujimoto, and S. Tsukita.
1998.
Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin.
J. Cell Biol.
141:1539-1550 |
| 25. |
Furuse, M.,
T. Hirase,
M. Itoh,
A. Nagafuchi,
S. Yonemura, and S. Tsukita.
1993.
Occludin: a novel integral membrane protein localizing at tight junctions [see comments].
J. Cell Biol.
123:1777-1788 |
| 26. | Gazzinelli, R. T., I. P. Oswald, S. Hieny, S. L. James, and A. Sher. 1992. The microbicidal activity of interferon-gamma-treated macrophages against Trypanosoma cruzi involves an L-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-beta. Eur. J. Immunol. 22:2501-2506[Medline]. |
| 27. | Gazzinelli, R. T., M. Wysocka, S. Hieny, T. Scharton-Kersten, A. Cheever, R. Kuhn, W. Muller, G. Trinchieri, and A. Sher. 1996. In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha. J. Immunol. 157:798-805[Abstract]. |
| 28. | Gelfanov, V., V. Gelfanova, Y. G. Lai, and N. S. Liao. 1996. Activated alpha beta-CD8+, but not alpha alpha-CD8+, TCR-alpha beta+ murine intestinal intraepithelial lymphocytes can mediate perforin-based cytotoxicity, whereas both subsets are active in Fas-based cytotoxicity. J. Immunol. 156:35-41[Abstract]. |
| 29. | Guy-Grand, D., B. Cuenod-Jabri, M. Malassis-Seris, F. Selz, and P. Vassalli. 1996. Complexity of the mouse gut T cell immune system: identification of two distinct natural killer T-cell intraepithelial lineages. Eur. J. Immunol. 26:2248-2256[Medline]. |
| 30. | Guy-Grand, D., J. P. DiSanto, P. Henchoz, M. Malassis-Seris, and P. Vassalli. 1998. Small bowel enteropathy: role of intraepithelial lymphocytes and of cytokines (IL-12, IFN-gamma, TNF) in the induction of epithelial cell death and renewal. Eur. J. Immunol. 28:730-744[CrossRef][Medline]. |
| 31. |
Hamann, A.,
D. P. Andrew,
D. Jablonski-Westrich,
B. Holzmann, and E. C. Butcher.
1994.
Role of 4 integrins in lymphocyte homing to mucosal tissues in vivo.
J. Immunol.
152:3282-3293[Abstract].
|
| 32. |
Hoffman, R. A.,
G. Zhang,
N. C. Nussler,
S. L. Gleixner,
H. R. Ford,
R. L. Simmons, and S. C. Watkins.
1997.
Constitutive expression of inducible nitric oxide synthase in the mouse ileal mucosa.
Am. J. Physiol.
272:G383-G392 |
| 33. | Hosokawa, T., K. Kusugami, K. Ina, T. Ando, M. Shinoda, A. Imada, M. Ohsuga, T. Sakai, T. Matsuura, K. Ito, and K. Kaneshiro. 1999. Interleukin-6 and soluble interleukin-6 receptor in the colonic mucosa of inflammatory bowel disease. J. Gastroenterol. Hepatol. 14:987-996[CrossRef][Medline]. |
| 34. |
Hsieh, C. S.,
S. E. Macatonia,
C. S. Tripp,
S. F. Wolf,
A. O'Garra, and K. M. Murphy.
1993.
Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages [see comments].
Science
260:547-549 |
| 35. | Ina, K., K. Kusugami, T. Hosokawa, A. Imada, T. Shimizu, T. Yamaguchi, M. Ohsuga, K. Kyokane, T. Sakai, Y. Nishio, Y. Yokoyama, and T. Ando. 1999. Increased mucosal production of granulocyte colony-stimulating factor is related to a delay in neutrophil apoptosis in inflammatory bowel disease. J. Gastroenterol. Hepatol. 14:46-53[CrossRef][Medline]. |
| 36. |
Iwasaki, A., and B. L. Kelsall.
1999.
Mucosal immunity and inflammation. I. Mucosal dendritic cells: their specialized role in initiating T cell responses.
Am. J. Physiol.
276:G1074-G1078 |
| 37. |
James, S. L.
1995.
Role of nitric oxide in parasitic infections.
Microbiol. Rev.
59:533-547 |
| 38. | Kaiserlian, D., K. Vidal, and J. P. Revillard. 1989. Murine enterocytes can present soluble antigen to specific class II- restricted CD4+ T cells. Eur. J. Immunol. 19:1513-1516[Medline]. |
| 39. |
Katelaris, P. H.,
A. Naeem, and M. J. Farthing.
1995.
Attachment of Giardia lamblia trophozoites to a cultured human intestinal cell line.
Gut
37:512-518 |
| 40. | Kelsall, B., and W. Strober. 1997. Dendritic cells of the gastrointestinal tract. Semin. Immunopathol. 18:409-420[CrossRef][Medline]. |
| 41. |
Khan, I. A.,
T. Matsuura, and L. H. Kasper.
1996.
Activation-mediated CD4+ T cell unresponsiveness during acute Toxoplasma gondii infection in mice.
Int. Immunol.
8:887-896 |
| 42. |
Khan, I. A.,
J. D. Schwartzmann,
T. Matsuura, and L. H. Kasper.
1997.
A dichotomous role for nitric oxide during acute Toxoplasma gondii infection in mice.
Proc. Natl. Acad. Sci. USA
94:13955-13960 |
| 43. | Kilshaw, P. J., and S. J. Murant. 1990. A new surface antigen on intraepithelial lymphocytes in the intestine. Eur. J. Immunol. 20:2201-2207[Medline]. |
| 44. | Kim, J. M., H. C. Jung, K. I. Im, I. S. Song, and C. Y. Kim. 1998. Synergy between Entamoeba histolytica and Escherichia coli in the induction of cytokine gene expression in human colon epithelial cells. Parasitol. Res. 84:509-512[Medline]. |
| 45. | Kim, S. K., D. S. Reed, W. R. Heath, F. Carbone, and L. Lefrancois. 1997. Activation and migration of CD8 T cells in the intestinal mucosa. J. Immunol. 159:4295-4306[Abstract]. |
| 46. | Laurent, F., L. Eckmann, T. C. Savidge, G. Morgan, C. Theodos, M. Nacirii, and M. F. Kagnoff. 1997. Cryptosporidium parvum infection of human intestinal epithelial cells induces the polarized secretion of C-X-C chemokines. Infect. Immun. 65:5067-5073[Abstract]. |
| 47. |
Laurent, F.,
M. F. Kagnoff,
T. C. Savidge,
M. Naciri, and L. Eckmann.
1998.
Human intestinal epithelial cells respond to Cryptosporidium parvum infection with increased prostaglandin H synthase 2 expression and prostaglandin E2 and F2 production.
Infect. Immun.
66:1787-1790 |
| 48. | Laurent, F., D. McCole, L. Eckmann, and M. F. Kagnoff. 1999. Pathogenesis of Cryptosporidium parvum infection. Microbes Infect. 1:141-148[CrossRef][Medline]. |
| 49. | Lefrancois, L., B. Fuller, J. W. Huleatt, S. Olson, and L. Puddington. 1997. On the front lines: intraepithelial lymphocytes as primary effectors of intestinal immunity. Semin. Immunopathol. 18:463-475[CrossRef][Medline]. |
| 50. |
Lepage, A. C.,
D. Buzoni-Gatel,
D. T. Bout, and L. H. Kasper.
1998.
Gut-derived intraepithelial lymphocytes induce long term immunity against Toxoplasma gondii.
J. Immunol.
161:4902-4908 |
| 51. | Leroy, A., G. De Bruyne, A. Verspeelt, T. Lauwaet, H. Nelis, and M. Mareel. 1997. Bacterium-assisted invasion of Entamoeba histolytica through human enteric epithelia in two-compartment chambers. Invasion Metastasis 17:138-148[Medline]. |
| 52. |
Leroy, A.,
T. Lauwaet,
G. De Bruyne,
M. Cornelissen, and M. Mareel.
2000.
Entamoeba histolytica disturbs the tight junction complex in human enteric T84 cell layers.
FASEB J.
14:1139-1146 |
| 53. |
Letterio, J. J.
2000.
Murine models define the role of TGF- as a master regulator of immune cell function.
Cytokine Growth Factor Rev.
11:81-87[CrossRef][Medline].
|
| 54. |
Li, E.,
W. F. Stenson,
C. Kunz-Jenkins,
P. E. Swanson,
R. Duncan, and S. L. Stanley, Jr.
1994.
Entamoeba histolytica interactions with polarized human intestinal Caco-2 epithelial cells.
Infect. Immun.
62:5112-5119 |
| 55. |
Liesenfeld, O.,
J. Kosek,
J. S. Remington, and Y. Suzuki.
1996.
Association of CD4+ T cell-dependent, interferon-gamma-mediated necrosis of the small intestine with genetic susceptibility of mice to peroral infection with Toxoplasma gondii.
J. Exp. Med.
184:597-607 |
| 56. | Lillehoj, H. S., and J. M. Trout. 1996. Avian gut-associated lymphoid tissues and intestinal immune responses to Eimeria parasites. Clin. Microbiol. Rev. 9:349-360[Abstract]. |
| 57. | Lloyd, A. R., and J. J. Oppenheim. 1992. Poly's lament: the neglected role of the polymorphonuclear neutrophil in the afferent limb of the immune response. Immunol. Today 13:169-172[CrossRef][Medline]. |
| 58. | Lopez-Osuna, M., J. Arellano, and R. R. Kretschmer. 1992. The destruction of virulent Entamoeba histolytica by activated human eosinophils. Parasite Immunol. 14:579-586[Medline]. |
| 59. | MacDonald, T. T. 1992. Epithelial proliferation in response to gastrointestinal inflammation. Ann. N. Y. Acad. Sci. 664:202-209[Medline]. |
| 60. | Madara, J. L. 1998. Regulation of the movement of solutes across tight junctions. Annu. Rev. Physiol. 60:143-159[CrossRef][Medline]. |
| 61. | Martinez-Palomo, A., A. Gonzalez-Robles, B. Chavez, E. Orozco, S. Fernandez-Castelo, and A. Cervantes. 1985. Structural bases of the cytolytic mechanisms of Entamoeba histolytica. J. Protozool. 32:166-175[Medline]. |
| 62. | Mayer, L., D. Eisenhardt, P. Salomon, W. Bauer, R. Plous, and L. Piccinini. 1991. Expression of class II molecules on intestinal epithelial cells in humans. Differences between normal and inflammatory bowel disease [see comments]. Gastroenterology 100:3-12[Medline]. |
| 63. |
McCole, D. F.,
L. Eckmann,
F. Laurent, and M. F. Kagnoff.
2000.
Intestinal epithelial cell apoptosis following Cryptosporidium parvum infection.
Infect. Immun.
68:1710-1713 |
| 64. | McDonald, V. 1999. Gut intraepithelial lymphocytes and immunity to Coccidia. Parasitol. Today 15:483-487[CrossRef][Medline]. |
| 65. |
Monteleone, G.,
F. Trapasso,
T. Parrello,
L. Biancone,
A. Stella,
R. Iuliano,
F. Luzza,
A. Fusco, and F. Pallone.
1999.
Bioactive IL-18 expression is up-regulated in Crohn's disease.
J. Immunol.
163:143-147 |
| 66. | Moore, K. W., A. O'Garra, R. de Waal Malefyt, P. Vieira, and T. R. Mosmann. 1993. Interleukin-10. Annu. Rev. Immunol. 11:165-190[CrossRef][Medline]. |
| 67. | Moore, R., S. Tzipori, J. K. Griffiths, K. Johnson, L. De Montigny, and I. Lomakina. 1995. Temporal changes in permeability and structure of piglet ileum after site-specific infection by Cryptosporidium parvum. Gastroenterology 108:1030-1039[CrossRef][Medline]. |
| 68. | Nakamura, S., H. Ohtani, Y. Watanabe, K. Fukushima, T. Matsumoto, A. Kitano, K. Kobayashi, and H. Nagura. 1993. In situ expression of the cell adhesion molecules in inflammatory bowel disease. Evidence of immunologic activation of vascular endothelial cells. Lab. Investig. 69:77-85[Medline]. |
| 69. | Nelson, B. J., P. Ralph, S. J. Green, and C. A. Nacy. 1991. Differential susceptibility of activated macrophage cytotoxic effector reactions to the suppressive effects of transforming growth factor-beta 1. J. Immunol. 146:1849-1857[Abstract]. |
| 70. | Neurath, M. F., I. Fuss, G. Schurmann, S. Pettersson, K. Arnold, H. Muller-Lobeck, W. Strober, C. Herfarth, and K. H. Buschenfelde. 1998. Cytokine gene transcription by NF-kappa B family members in patients with inflammatory bowel disease. Ann. N. Y. Acad. Sci. 859:149-159[CrossRef][Medline]. |
| 71. | Ni, J., and D. Hollander. 1995. Expression of beta 7 integrins and other cell adhesion molecules on mouse lymphocytes and their modulation by a new cytokine, IL-2 receptor-inducing factor. Cell. Immunol. 164:150-155[CrossRef][Medline]. |
| 72. | Ojcius, D. M., J. L. Perfettini, A. Bonin, and L. Laurent. 1999. Caspase-dependent apoptosis during infection with C. parvum. Microbes Infect. 1:1163-1168[CrossRef][Medline]. |
| 73. | Ortaldo, J. R., A. T. Mason, J. J. O'Shea, M. J. Smyth, L. A. Falk, I. C. Kennedy, D. L. Longo, and F. W. Ruscetti. 1991. Mechanistic studies of transforming growth factor-beta inhibition of IL-2-dependent activation of CD3-large granular lymphocyte functions. Regulation of IL-2R beta (p75) signal transduction. J. Immunol. 146:3791-3798[Abstract]. |
| 74. | Pardoux, C., C. Asselin-Paturel, J. Chehimi, F. Gay, F. Mami-Chouaib, and S. Chouaib. 1997. Functional interaction between TGF-beta and IL-12 in human primary allogeneic cytotoxicity and proliferative response. J. Immunol. 158:136-143[Abstract]. |
| 75. |
Pfefferkorn, E. R., and P. M. Guyre.
1984.
Inhibition of growth of Toxoplasma gondii in cultured fibroblasts by human recombinant gamma interferon.
Infect. Immun.
44:211-216 |
| 76. | Plum, J., M. De Smedt, G. Leclercq, and B. Vandekerckhove. 1995. Influence of TGF-beta on murine thymocyte development in fetal thymus organ culture. J. Immunol. 154:5789-5798[Abstract]. |
| 77. |
Poussier, P., and M. Julius.
1994.
Intestinal intraepithelial lymphocytes: the plot thickens.
J. Exp. Med.
180:1185-1189 |
| 78. | Reis e Sousa, C., G. Yap, O. Schulz, N. Rogers, M. Schito, J. Aliberti, S. Hieny, and A. Sher. 1999. Paralysis of dendritic cell IL-12 production by microbial products prevents infection-induced immunopathology. Immunity 11:637-647[CrossRef][Medline]. |
| 79. | Ridel, P. R., C. Auriault, F. Darcy, R. J. Pierce, P. Leite, F. Santoro, J. L. Neyrinck, J. P. Kusnierz, and A. Capron. 1988. Protective role of IgE in immunocompromised rat toxoplasmosis. J. Immunol. 141:978-983[Abstract]. |
| 80. |
Roberts, A. I.,
M. Bilenker, and E. C. Ebert.
1997.
Intestinal intraepithelial lymphocytes have a promiscuous interleukin-8 receptor.
Gut
40:333-338 |
| 81. | Salzman, A. L., T. Eaves-Pyles, S. C. Linn, A. G. Denenberg, and C. Szabo. 1998. Bacterial induction of inducible nitric oxide synthase in cultured human intestinal epithelial cells. Gastroenterology 114:93-102[CrossRef][Medline]. |
| 82. | Schmitt, E., P. Hoehn, C. Huels, S. Goedert, N. Palm, E. Rude, and T. Germann. 1994. T helper type 1 development of naive CD4+ T cells requires the coordinate action of interleukin-12 and interferon-gamma and is inhibited by transforming growth factor-beta. Eur. J. Immunol. 24:793-798[Medline]. |
| 83. | Seguin, R., and L. H. Kasper. 1999. Sensitized lymphocytes and CD40 ligation augment IL-12 production by human dendritic cells in response to T. gondii. J. Infect. Dis. 179:467-474[CrossRef][Medline]. |
| 84. | Seguin, R., B. J. Mann, K. Keller, and K. Chadee. 1997. The tumor necrosis factor alpha-stimulating region of galactose-inhibitable lectin of Entamoeba histolytica activates gamma interferon-primed macrophages for amebicidal activity mediated by nitric oxide. Infect. Immun. 65:2522-2527[Abstract]. |
| 85. | Seydel, K. B., E. Li, P. E. Swanson, and S. L. Stanley, Jr. 1997. Human intestinal epithelial cells produce proinflammatory cytokines in response to infection in a SCID mouse-human intestinal xenograft model of amebiasis. Infect. Immun. 65:1631-1639[Abstract]. |
| 86. | Seydel, K. B., E. Li, Z. Zhang, and S. L. J. Stanley. 1998. Epithelial cell-initiated inflammation plays a crucial role in early tissue damage in amebic infection of human intestine. Gastroenterology 115:1446-1453[CrossRef][Medline]. |
| 87. |
Seydel, K. B.,
T. Zang,
G. A. Champion,
C. Fichtenbaum,
P. E. Swanson,
S. Tzipori,
J. K. Griffiths, and S. L. Stanley.
1998.
Cryptosporidium parvum infection of human intestinal xenografts in SCID mice induces production of human tumor necrosis factor alpha and interleukin-8.
Infect. Immun.
66:2379-2382 |
| 88. | Sher, A., R. T. Gazzinelli, I. P. Oswald, M. Clerici, M. Kullberg, E. J. Pearce, J. A. Berzofsky, T. R. Mosmann, S. L. James, and H. C. Morse, III. 1992. Role of T-cell derived cytokines in the downregulation of immune responses in parasitic and retroviral infection. Immunol. Rev. 127:183-204[CrossRef][Medline]. |
| 89. | Speer, C. A., and J. P. Dubey. 1998. Ultrastructure of early stages of infections in mice fed Toxoplasma gondii oocysts. Parasitology 116:35-42. |
| 90. |
Suzuki, Y.,
A. Sher,
G. Yap,
D. Park,
L. E. Neyer,
O. Liesenfeld,
M. Fort,
H. Kang, and E. Gufwoli.
2000.
IL-10 prevents necrosis in the small intestine and mortality in both genetically resistant BALB/c and susceptible C57BL/6 mice following peroral infection with Toxoplasma gondii.
J. Immunol.
164:5375-5382 |
| 91. |
Takeuchi, M.,
P. Alard, and J. W. Streilein.
1998.
TGF-beta promotes immune deviation by altering accessory signals of antigen-presenting cells.
J. Immunol.
160:1589-1597 |
| 92. | Tidswell, M., R. Pachynski, S. W. Wu, S. Q. Qiu, E. Dunham, N. Cochran, M. J. Briskin, P. J. Kilshaw, A. I. Lazarovits, D. P. Andrew, E. C. Butcher, T. A. Yednock, and D. J. Erle. 1997. Structure-function analysis of the integrin beta 7 subunit: identification of domains involved in adhesion to MAdCAM-1. J. Immunol. 159:1497-1505[Abstract]. |
| 93. | Vervelde, L., A. N. Vermeulen, and S. H. Jeurissen. 1996. In situ characterization of leucocyte subpopulations after infection with Eimeria tenella in chickens. Parasite Immunol. 18:247-256[CrossRef][Medline]. |
| 94. |
Villegas, E. N.,
U. Wille,
L. Craig,
P. S. Iinsley,
D. M. Rennick,
R. Peach, and C. A. Hunter.
2000.
Blockade of costimulation prevents infection-induced immunopathology in interleulin-10-deficient mice.
Infect. Immun.
68:2837-2844 |
| 95. | Vinayak, V. K., R. Khanna, and K. Kum. 1991. Kinetics of intraepithelium and lamina propria lymphocyte responses during Giardia lamblia infection in mice. Microb. Pathog. 10:343-350[CrossRef][Medline]. |
| 96. | Wagner, N., J. Lohler, E. J. Kunkel, K. Ley, E. Leung, G. Krissansen, K. Rajewsky, and W. Muller. 1996. Critical role for beta7 integrins in formation of the gut-associated lymphoid tissue. Nature 382:366-370[CrossRef][Medline]. |
| 97. |
Witthoft, T.,
L. Eckmann,
J. M. Kim, and M. F. Kagnoff.
1998.
Enteroinvasive bacteria directly activate expression of iNOS and NO production in human colon epithelial cells.
Am. J. Physiol.
275:G564-G571 |
| 98. |
Yamamoto, M.,
K. Fujihashi,
K. Kawabata,
J. R. McGhee, and H. Kiyono.
1998.
A mucosal intranet: intestinal epithelial cells down-regulate intraepithelial, but not peripheral, T lymphocytes.
J. Immunol.
160:2188-2196 |
| 99. | Yu, Y., and K. Chadee. 1997. Entamoeba histolytica stimulates interleukin 8 from human colonic epithelial cells without parasite-enterocyte contact. Gastroenterology 112:1536-1547[CrossRef][Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»